The Role of Ultrasonography in Pregnancy in the Study of Fetal Central Nervous System Malformations
CNS_2021
1 other identifier
observational
80
1 country
1
Brief Summary
The aim of this observational study is to evaluate the correlation between new ultrasound patterns and fetal central nervous system (CNS) malformations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2021
CompletedFirst Submitted
Initial submission to the registry
December 3, 2024
CompletedFirst Posted
Study publicly available on registry
January 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 30, 2025
October 1, 2024
5.2 years
December 3, 2024
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between new ultrasound patterns and fetal CNS malformations
Retrospectively analyze ultrasound images of fetuses with established brain malformations
up to 100 weeks
Secondary Outcomes (1)
Comparison of ultrasound patterns found in fetuses with and without CNS malformations
up to 100 weeks
Study Arms (2)
Fetus with CNS malformations
Evaluation of ultrasound images routinely performed during pregnancy in fetuses with brain malformation
Fetus withous CNS malformations
Evaluation of ultrasound images routinely performed during pregnancy in healthy fetuses
Interventions
Ultrasound images acquired during routine ultrasound scans performed in healthy fetuses and in fetuses found to have CNS malformations will be reviewed. Ultrasound images acquired from January 2000 to May 2021 will be analyzed until a sample size of approximately 80 patients is reached, who will be divided into 2 groups: group A (patients whose fetus has CNS malformations) and group B (healthy patients whose fetus has no anatomical CNS abnormalities).
Eligibility Criteria
Participants will be divided into 2 groups: group A (patients whose fetus has central nervous system malformations) and group B (healthy patients whose fetus has no anatomical abnormalities of the central nervous system).
You may qualify if:
- Women older than 18 years with single pregnancy and fetus with ultrasound diagnosis of central nervous system malformation (group A)
- Women with single pregnancy and normoconformed fetuses (group B).
You may not qualify if:
- Twin pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Gianluigi Pilu, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2024
First Posted
January 23, 2025
Study Start
October 11, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 30, 2025
Record last verified: 2024-10